OnKure Therapeutics ($OKUR) Insider Trading & Smart Money Activity

OnKure Therapeutics, Inc. · Latest filing Sep 21, 2026

OnKure Therapeutics, Inc. ($OKUR) has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($1.16K), net -$1.16K.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

2

Net insider $ (12 mo)

-$1.16K

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

OKUR insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	2 · $1.16K	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All OKUR insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Sep 21, 2026	Insider	Saccomano Nicholas APresident and CEO	Sell (Open-market sale)	87 sh	$258.76						—
Sep 21, 2026	Insider	Leverone Jason A.Chief Financial Officer	Sell (Open-market sale)	302 sh	$898.21						—

1W / 1M / 6M = how OKUR moved from the trade or filing date.

Insider trading in OKUR: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Saccomano Nicholas A	President and CEO	1	-$258.76		Sep 21, 2026
Leverone Jason A.	Chief Financial Officer	1	-$898.21		Sep 21, 2026

Frequently asked questions

Are OKUR insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $1.16K, a net -$1.16K.

What is the latest insider trade in OKUR?

Saccomano Nicholas A, President and CEO filed a sell (open-market sale) of 87 sh worth $258.76 on Sep 21, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.